Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Tanni, A. Angeleli, N. Pelegrino, C. Correa-Camacho, C. Correa, L. Inoue, I. Godoy (Botucatu/Sao Paulo, Brazil; Seatle, WA, United States Of America). Influence of active smoking on systemic TNF-α concentration in COPD patients. Eur Respir J 2008; 32: Suppl. 52, 1816

Member's Comments

No comment yet.

Related content which might interest you: Effect of smoking on lung functions in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 157s Year: 2005 The influence of smoking on hydrolipoperoxidation in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 306s Year: 2003 Influence of smoking on airway and systemic inflammation in healthy subjects and COPD patients Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007 Systemic inflammation in COPD in relation to smoking status Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities Year: 2020 Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Effects of smoking history on the benefits of pulmonary rehabilitation in patients with COPD Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 The influence of smoking on the treatment response in patients with asthma Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 Influence of smoking intensity and smoking quitting on lung function parameters in COPD patients Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders Year: 2011 Influence of tobacco-smoking and it intensification on systemic inflammatory state (sis) in COPD patients Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006 Influence of statin therapy on exacerbation frequency in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Effect of smoking cessation on sputum HNP levels in COPD patients and asymptomatic smokers Source: Annual Congress 2008 - Towards smoking cessation Year: 2008 Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 The effect of smoking on exacerbation risk in eosinophilic patients with COPD Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017 Year: 2017 The effect of smoking on exacerbation risk in eosinophilic patients with COPD Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017 Year: 2017 Comparison of osteoporosis in male smokers with or without COPD Source: International Congress 2016 – Smoking-related diseases Year: 2016 Influence of tobacco smoking on respiratory muscles function in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005